Nano polymeric carrier fabrication technologies for advanced antitumor therapy

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Li, Wei ^a,b,c,d   Zhao, Mengxin ^a,d   Ke, Changhong ^a,e   Zhang, Ge ^a   Zhang, Li ^a   Li, Huafei ^a   Zhang, Fulei ^a,d   Sun, Yun ^a   Dai, Jianxin ^a,b,c,d,e   Wang, Hao ^a,b,c,d,e   Guo, Yajun ^a,b,c,d,e  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Shanghai Key Laboratory of Complex Prescription   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

^d LIAOCHENG UNIVERSITY   (China)

^e JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; NANOPARTICLE; POLYMER;

ARTICLE; CHEMISTRY; HUMAN; IMMUNOTHERAPY; METHODOLOGY; NANOMEDICINE; NEOPLASM;

DRUG CARRIERS; HUMANS; IMMUNOTHERAPY; NANOMEDICINE; NANOPARTICLES; NEOPLASMS; POLYMERS;

EID: 84893815254     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/305089     Document Type: Review

References (66)

1. A.C. Society Cancer Facts & Figures 2012, 2012
2. Li W., Feng S., Guo Y., Tailoring polymeric micelles to optimize delivery to solid tumors. Nanomedicine 2012 7 1235 1252
3. Li W., Feng S.-S., Guo Y., Block copolymer micelles for nanomedicine. Nanomedicine 2012 7 2 169 172 2-s2.0-84857537003 10.2217/nnm.11.182
4. Li W., Zhao H., Qian W., Li H., Zhang L., Ye Z., Zhang G., Xia M., Li J., Gao J., Li B., Kou G., Dai J., Wang H., Guo Y., Chemotherapy for gastric cancer by finely tailoring anti-Her2 anchored dual targeting immunomicelles. Biomaterials 2012 33 5349 5362 2-s2.0-84860110930 10.1016/j.biomaterials.2012. 04.016
5. Lesterhuis W. J., Haanen J. B. A. G., Punt C. J. A., Cancer immunotherapy-revisited. Nature Reviews Drug Discovery 2011 10 8 591 600 2-s2.0-79961011492 10.1038/nrd3500
6. Sheng W.-Y., Huang L., Cancer immunotherapy and nanomedicine. Pharmaceutical Research 2011 28 2 200 214 2-s2.0-79952486562 10.1007/s11095-010-0258-8
7. Bolhassani A., Safaiyan S., Rafati S., Improvement of different vaccine delivery systems for cancer therapy. Molecular Cancer 2011 10, article 3 2-s2.0-78650949758 10.1186/1476-4598-10-3
8. Dillman R. O., Cancer immunotherapy. Cancer Biotherapy and Radiopharmaceuticals 2011 26 1 1 64 2-s2.0-79952140079 10.1089/cbr.2010.0902
9. Carstens M. G., Opportunities and challenges in vaccine delivery. European Journal of Pharmaceutical Sciences 2009 36 4-5 605 608 2-s2.0-59349085503 10.1016/j.ejps.2008.11.004
10. Young K. R., McBurney S. P., Karkhanis L (Pubitemid 44415502)
11. Michel M.-L., Tiollais P., Hepatitis B vaccines: protective efficacy and therapeutic potential. Pathologie Biologie 2010 58 4 288 295 2-s2.0-77955421572 10.1016/j.patbio.2010.01.006
12. Hamdy S., Haddadi A., Hung R. W., Lavasanifar A., Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations. Advanced Drug Delivery Reviews 2011 63 10-11 943 955 2-s2.0-80052270541 10.1016/j.addr.2011. 05.021
13. Roldão A., Mellado M. C. M., Castilho L. R., Carrondo M. J. T., Alves P. M., Virus-like particles in vaccine development. Expert Review of Vaccines 2010 9 10 1149 1176 2-s2.0-77957936654 10.1586/erv.10.115
14. Noad R., Roy P., Virus-like particles as immunogens. Trends in Microbiology 2003 11 9 438 444 2-s2.0-0042825878 10.1016/S0966-842X(03)00208-7 (Pubitemid 37101484)
15. Lin J. H., Lu A. Y. H., Role of pharmacokinetics and metabolism in drug discovery and development. Pharmacological Reviews 1997 49 4 403 449 2-s2.0-0031472588 (Pubitemid 28030947)
16. Lukyanov A. N., Torchilin V. P., Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Advanced Drug Delivery Reviews 2004 56 9 1273 1289 2-s2.0-1942486331 10.1016/j.addr.2003. 12.004 (Pubitemid 38510474)
17. Kwon G. S., Kataoka K., Block copolymer micelles as long-circulating drug vehicles. Advanced Drug Delivery Reviews 1995 16 2-3 295 309 2-s2.0-0029360757 10.1016/0169-409X(95)00031-2
18. Jeong B., Bae Y. H., Kim S. W., Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers. Journal of Controlled Release 2000 63 1-2 155 163 2-s2.0-0142210489 10.1016/S0168-3659(99)00194-7 (Pubitemid 30046951)
19. Barenholz Y., Doxil®-the first FDA-approved nano-drug: lessons learned. Journal of Controlled Release 2012 160 117 134 2-s2.0-84859715261 10.1016/j.jconrel.2012.03.020
20. Wagner V., Dullaart A., Bock A.-K., Zweck A., The emerging nanomedicine landscape. Nature Biotechnology 2006 24 10 1211 1217 2-s2.0-33749820952 10.1038/nbt1006-1211 (Pubitemid 44564760)
21. Ferrari M., Cancer nanotechnology: opportunities and challenges. Nature Reviews Cancer 2005 5 3 161 171 2-s2.0-14644439267 10.1038/nrc1566 (Pubitemid 40314948)
22. He L., Wang G.-L., Zhang Q., An alternative paclitaxel microemulsion formulation: hypersensitivity evaluation and pharmacokinetic profile. International Journal of Pharmaceutics 2003 250 1 45 50 2-s2.0-0037413394 10.1016/S0378-5173(02)00478-7 (Pubitemid 35447936)
23. Feng Z., Zhao G., Yu L., Gough D., Howell S. B., Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane. Cancer Chemotherapy and Pharmacology 2010 65 5 923 930 2-s2.0-77649190943 10.1007/s00280-009-1099-1
24. Alexis F., Pridgen E., Molnar L. K., Farokhzad O. C., Factors affecting the clearance and biodistribution of polymeric nanoparticles. Molecular Pharmaceutics 2008 5 4 505 515 2-s2.0-51049092308 10.1021/mp800051m
25. Matsumura Y., Maeda H., A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Research 1986 46 12 6387 6392 2-s2.0-0022858683 (Pubitemid 17221789)
26. Talelli M., Iman M., Varkouhi A. K., Rijcken C. J. F., Schiffelers R. M., Etrych T., Ulbrich K., van Nostrum C. F., Lammers T., Storm G., Hennink W. E., Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin. Biomaterials 2010 31 30 7797 7804 2-s2.0-77955768765 10.1016/j.biomaterials.2010.07.005
27. Lukyanov A. N., Torchilin V. P., Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Advanced Drug Delivery Reviews 2004 56 9 1273 1289 2-s2.0-1942486331 10.1016/j.addr.2003. 12.004 (Pubitemid 38510474)
28. Kakizawa Y., Kataoka K., Block copolymer micelles for delivery of gene and related compounds. Advanced Drug Delivery Reviews 2002 54 2 203 222 2-s2.0-0037148675 10.1016/S0169-409X(02)00017-0 (Pubitemid 34230442)
29. Kakizawa Y., Kataoka K., Block copolymer micelles for delivery of gene and related compounds. Advanced Drug Delivery Reviews 2002 54 2 203 222 2-s2.0-0037148675 10.1016/S0169-409X(02)00017-0 (Pubitemid 34230442)
30. Kabanov A. V., Nazarova I. R., Astafieva I. V., Batrakova E. V., Alakhov V. Y., Yaroslavov A. A., Kabanov V. A., Micelle formation and solubilization of fluorescent probes in poly(oxyethylene-b-oxypropylene-b-oxyethylene) solutions. Macromolecules 1995 28 7 2303 2314 2-s2.0-0000468178
31. Brown J. M., Giaccia A. J., The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Research 1998 58 7 1408 1416 2-s2.0-0032053823 (Pubitemid 28193601)
32. Yahara T., Koga T., Yoshida S., Nakagawa S., Deguchi H., Shirouzo K., Relationship between microvessel density and thermographic hot areas in breast cancer. Surgery Today 2003 33 4 243 248 2-s2.0-0037880675 10.1007/s005950300055 (Pubitemid 36549578)
33. Bae Y., Nishiyama N., Fukushima S., Koyama H., Yasuhiro M., Kataoka K., Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjugate Chemistry 2005 16 1 122 130 2-s2.0-12344269847 10.1021/bc0498166 (Pubitemid 40129685)
34. Kwon G., Suwa S., Yokoyama M., Okano T., Sakurai Y., Kataoka K., Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-adriamycin conjugates. Journal of Controlled Release 1994 29 1-2 17 23 2-s2.0-0028346185
35. Nakayama M., Okano T., Miyazaki T., Kohori F., Sakai K., Yokoyama M., Molecular design of biodegradable polymeric micelles for temperature-responsive drug release. Journal of Controlled Release 2006 115 1 46 56 2-s2.0-33748870763 10.1016/j.jconrel.2006.07.007 (Pubitemid 44419528)
36. Akimoto J., Nakayama M., Sakai K., Okano T., Temperature-induced intracellular uptake of thermoresponsive polymeric micelles. Biomacromolecules 2009 10 6 1331 1336 2-s2.0-67049115688 10.1021/bm900032r
37. Takae S., Miyata K., Oba M., Ishii T., Nishiyama N., Itaka K., Yamasaki Y., Koyama H., Kataoka K., PEG-detachable polyplex micelles based on disulfide-linked block catiomers as bioresponsive nonviral gene vectors. Journal of the American Chemical Society 2008 130 18 6001 6009 2-s2.0-42949103542 10.1021/ja800336v (Pubitemid 351620847)
38. Zhang Z. Z., Tan S. W., Feng S.-S., Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials 2012 33 19 4889 4906 2-s2.0-84859839124 10.1016/j.biomaterials.2012.03.046
39. Mi Y., Liu Y., Feng S.-S., Formulation of Docetaxel by folic acid-conjugated D- α -tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS2k) micelles for targeted and synergistic chemotherapy. Biomaterials 2011 32 16 4058 4066 2-s2.0-79953026443 10.1016/j.biomaterials. 2011.02.022
40. Lee H.-I., Wu W., Oh J. K., Mueller L., Sherwood G., Peteanu L., Kowalewski T., Matyjaszewski K., Light-induced reversible formation of polymeric micelles. Angewandte Chemie 2007 46 14 2453 2457 2-s2.0-34250895570 10.1002/anie.200604278 (Pubitemid 46973589)
41. Nasongkla N., Bey E., Ren J., Ai H., Khemtong C., Guthi J. S., Chin S.-F., Sherry A. D., Boothman D. A., Gao J., Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Letters 2006 6 11 2427 2430 2-s2.0-33846160552 10.1021/nl061412u (Pubitemid 46076928)
42. Li W., Li J., Gao J., Li B., Xia Y., Meng Y., Yu Y., Chen H., Dai J., Wang H., Guo Y., The fine-tuning of thermosensitive and degradable polymer micelles for enhancing intracellular uptake and drug release in tumors. Biomaterials 2011 32 15 3832 3844 2-s2.0-79952750426 10.1016/j.biomaterials. 2011.01.075
43. Li W., Nakayama M., Akimoto J., Okano T., Effect of block compositions of amphiphilic block copolymers on the physicochemical properties of polymeric micelles. Polymer 2011 52 17 3783 3790 2-s2.0-79961030148 10.1016/j.polymer. 2011.06.026
44. Gao J., Feng S.-S., Guo Y., Antibody engineering promotes nanomedicine for cancer treatment. Nanomedicine 2010 5 8 1141 1145 2-s2.0-78149329133 10.2217/nnm.10.94
45. Feldmann M., Steinman L., Design of effective immunotherapy for human autoimmunity. Nature 2005 435 7042 612 619 2-s2.0-20444489218 10.1038/nature03727 (Pubitemid 40825501)
46. Herber D. L., Cao W., Nefedova Y., Novitskiy S. V., Nagaraj S., Tyurin V. A., Corzo A., Cho H.-I., Celis E., Lennox B., Knight S. C., Padhya T., McCaffrey T. V., McCaffrey J. C., Antonia S., Fishman M., Ferris R. L., Kagan V. E., Gabrilovich D. I., Lipid accumulation and dendritic cell dysfunction in cancer. Nature Medicine 2010 16 8 880 886 2-s2.0-77955344402 10.1038/nm.2172
47. Elamanchili P., Diwan M., Cao M., Samuel J., Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells. Vaccine 2004 22 19 2406 2412 2-s2.0-2942562255 10.1016/j.vaccine.2003.12.032 (Pubitemid 38757337)
48. + T cells during the effector phase. Journal of Experimental Medicine 2010 207 11 2469 2477 2-s2.0-78149309084 10.1084/jem.20092450
49. Schuster M., Nechansky A., Kircheis R., Cancer immunotherapy. Biotechnology Journal 2006 1 2 138 147 2-s2.0-33750587073 10.1002/biot.200500044
50. Ganss R., Hanahan D., Tumor microenvironment can restrict the effectiveness of activated antitumor lymphocytes. Cancer Research 1998 58 20 4673 4681 2-s2.0-0032532318 (Pubitemid 28480634)
51. Kim R., Emi M., Tanabe K., Cancer immunoediting from immune surveillance to immune escape. Immunology 2007 121 1 1365 2567 2-s2.0-34047220868 10.1111/j.1365-2567.2007.02587.x (Pubitemid 46537674)
52. Dunn G. P., Old L. J., Schreiber R. D., The immunobiology of cancer immunosurveillance and immunoediting. Immunity 2004 21 2 137 148 2-s2.0-4143141823 10.1016/j.immuni.2004.07.017 (Pubitemid 39094044)
53. Liu Z., Winters M., Holodniy M., Dai H., siRNA delivery into human T cells and primary cells with carbon-nanotube transporters. Angewandte Chemie 2007 46 12 2023 2027 2-s2.0-34247582332 10.1002/anie.200604295 (Pubitemid 46973660)
54. Williams L. M., Rudensky A. Y., Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nature Immunology 2007 8 3 277 284 2-s2.0-34247271308 10.1038/ni1437 (Pubitemid 46745377)
55. Zhang Z., Tongchusak S., Mizukami Y., Kang Y. J., Ioji T., Touma M., Reinhold B., Keskin D. B., Reinherz E. L., Sasada T., Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery. Biomaterials 2011 32 14 3666 3678 2-s2.0-79952106754 10.1016/j.biomaterials. 2011.01.067
56. Li W., Zhang L., Zhang G., The finely regulating well-defined functional polymer nanocarriers for anti-tumor immunotherapy. Mini-Reviews in Medicinal Chemistry 2013 13 643 652
57. Li W., Guo Q., Zhao H., Zhang L., Li J., Gao J., Qian W., Li B., Chen H., Wang H., Dai J., Guo Y., Novel dual-control poly(N -isopropylacrylamide- c -chlorophyllin) nanogels for improving drug release. Nanomedicine 2012 7 3 383 392 2-s2.0-84857816641 10.2217/nnm.11.100
58. Li W., Feng S., Guo Y., Nanocarrier's engineering for immunotherapy. Nanomedicine 2013 8 5
59. Li W., Li J., Li H., Self-assembled supramolecular nano vesicles for safe and highly efficient gene delivery to solid tumors. International Journal of Nanomedicine 2012 7 4661 4677
60. Ayano E., Karaki M., Ishihara T., Kanazawa H., Okano T., Poly (N-isopropylacrylamide)-PLA and PLA blend nanoparticles for temperature- controllable drug release and intracellular uptake. Colloids and Surfaces B 2012 99 4661 4677 2-s2.0-80855144722 10.1016/j.colsurfb.2011.10.003
61. Moon J. J., Suh H., Bershteyn A., Stephan M. T., Liu H., Huang B., Sohail M., Luo S., Ho Um S., Khant H., Goodwin J. T., Ramos J., Chiu W., Irvine D. J., Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses. Nature Materials 2011 10 3 243 251 2-s2.0-79951899834 10.1038/nmat2960
62. Fischer D., Li Y., Ahlemeyer B., Krieglstein J., Kissel T., In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 2003 24 7 1121 1131 2-s2.0-0346634895 10.1016/S0142-9612(02)00445-3 (Pubitemid 36069121)
63. Zou W., Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nature Reviews Cancer 2005 5 4 263 274 2-s2.0-16844379997 10.1038/nrc1586 (Pubitemid 40488632)
64. Zhuang Y., Ma Y., Wang C., Hai L., Yan C., Zhang Y., Liu F., Cai L., PEGylated cationic liposomes robustly augment vaccine-induced immune responses: role of lymphatic trafficking and biodistribution. Journal of Controlled Release 2012 159 1 135 142 2-s2.0-84859481643 10.1016/j.jconrel.2011.12.017
65. Champion J. A., Mitragotri S., Role of target geometry in phagocytosis. Proceedings of the National Academy of Sciences of the United States of America 2006 103 13 4930 4934 2-s2.0-33645533255 10.1073/pnas.0600997103
66. Ding B., Wu X., Fan W., Wu Z., Gao J., Zhang W., Ma L., Xiang W., Zhu Q., Liu J., Ding X., Gao S., Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activity. International Journal of Nanomedicine 2011 6 1991 2005 2-s2.0-84859244626